Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/11796334

Download in:

View as

General Info

PMID
11796334